Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant

Saved in:
Bibliographic Details
Published inSignal transduction and targeted therapy Vol. 7; no. 1; p. 173
Main Authors Tai, Wanbo, Chai, Benjie, Feng, Shengyong, Zhuang, Xinyu, Ma, Jun, Pang, Mujia, Pan, Lin, Yang, Zi, Tian, Mingyao, Cheng, Gong
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2022
Nature Publishing Group
Subjects
631/250/590
631/326/590
Cancer Research
Cell Biology
Ferritin
Internal Medicine
Letter
Medicine
Medicine & Public Health
Nanoparticles
Oncology
Pathology
Severe acute respiratory syndrome coronavirus 2
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:2059-3635
2095-9907
2059-3635
DOI:10.1038/s41392-022-01041-8